Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1996
10/31/1996WO1996033741A1 Remedy for allergic diseases in the region of the nose
10/31/1996WO1996033734A1 A pluripotent vaccine against enveloped viruses
10/31/1996WO1996033732A1 Multimeric, recombinant urease vaccine
10/31/1996WO1996033726A1 Preparation and use of sulfated oligosaccharides
10/31/1996WO1996033725A1 Solvent detergent emulsions having antiviral activity
10/31/1996WO1996033724A2 Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
10/31/1996WO1996033723A2 Use of benzamide derivatives for treating and/or preventing meniere's syndrome and motion sickness
10/31/1996WO1996033722A1 External preparation containing emedastine
10/31/1996WO1996033721A1 Anti-emetic pharmaceutical compositions containing methotrimeprazine
10/31/1996WO1996033720A1 Use of (r)-penciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases
10/31/1996WO1996033719A1 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
10/31/1996WO1996033718A1 Agent for severe acute pancreatitis
10/31/1996WO1996033716A1 RARβ SELECTIVE RETINOID COMPOUNDS FOR INHIBITING GENE EXPRESSION PROMOTED BY AP1 PROTEIN AND THEIR USE IN THERAPY
10/31/1996WO1996033715A1 Novel use of pyrazolopyridine compounds
10/31/1996WO1996033714A1 Treatment of actinic keratosis, displastic nevi and other proliferative skin disorders with topical clotrimazole
10/31/1996WO1996033713A1 Indazolecarboxamides
10/31/1996WO1996033711A2 Use of thioketene derivatives for preventing or treating hepatitis b
10/31/1996WO1996033710A1 A combination of a 5-ht uptake inhibitor with a selective 5-ht1a antagonist
10/31/1996WO1996033709A1 Topical treatment and/or prevention of sagging subcutaneous muscle and overlying cutaneous tissue using acetylcholine precursors and catecholamines
10/31/1996WO1996033708A1 Irritation relief using nonsteroidal anti-inflammatory compounds
10/31/1996WO1996033707A1 Topical preparation for promoting muscular development
10/31/1996WO1996033706A1 Compositions and methods for inducing dermal analgesia
10/31/1996WO1996033705A1 Methods and formulations for modulating the human sexual response
10/31/1996WO1996033704A1 Preparation for oral administration
10/31/1996WO1996033703A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
10/31/1996WO1996033701A1 Inhibiting photodecomposition of 3-substituted-2-oxindoles
10/31/1996WO1996033700A1 Controlled release formulation for water soluble drugs in which a passageway is formed in situ
10/31/1996WO1996033696A1 Novel collagen formulations
10/31/1996WO1996033678A1 Triacetin as a transdermal penetration enhancer
10/31/1996WO1996029063A3 Pinitol and derivatives thereof for the treatment of metabolic disorders
10/31/1996WO1996027663A3 An antisense transcript associated to tumor cells having a t(14;18) translocation and oligodeoxynucleotides useful in the diagnosis and treatment of said tumor cells
10/31/1996WO1996027384A3 Composition for treating skin conditions comprising an inhibitor of skin iso-phosphodiesterase
10/31/1996WO1990005444A3 Oral liquid pharmaceutical compositions of sulindac
10/31/1996DE19515500A1 Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Substituted phenylamidines, pharmaceutical compositions containing them and methods for their preparation
10/31/1996DE19515297A1 Use of 2-(2,6-di:fluorophenyl)-4-(4-(4-tri:fluoromethoxy-phenyl)-phenyl)-2- oxazoline
10/31/1996DE19515296A1 Use of oxazoline derivs.
10/31/1996DE19515275A1 Neue Verwendung von (S)-Adenosyl-L-methionin(SAMe) New use of (S) -Adenosyl-L-methionine (SAMe)
10/31/1996CA2219571A1 Novel substituted tetrahydropyrano[3,2-d]oxazolones, method for their preparation and pharmaceutical compositions containing them
10/31/1996CA2219339A1 A pluripotent vaccine against enveloped viruses
10/31/1996CA2219337A1 Substituted phenylamidines, pharmaceutical compositions containing these compounds and processes for preparing them
10/31/1996CA2219226A1 Irritation relief using nonsteroidal anti-inflammatory compounds
10/31/1996CA2219214A1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
10/31/1996CA2219201A1 Multimeric, recombinant urease vaccine
10/31/1996CA2219028A1 Rar.beta. selective retinoid compounds for inhibiting gene expression promoted by ap1 protein and their use in therapy
10/31/1996CA2218955A1 Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
10/31/1996CA2218492A1 Decorin binding protein compositions and methods of use
10/31/1996CA2218181A1 A combination of a 5-ht uptake inhibitor with a selective 5-ht1a antagonist
10/31/1996CA2218037A1 Novel collagen formulations
10/31/1996CA2217696A1 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
10/31/1996CA2216931A1 Inhibiting photodecomposition of 3-substituted-2-oxindoles
10/31/1996CA2216532A1 Inhibitors of farnesyl-protein transferase
10/31/1996CA2215359A1 Indazolecarboxamides
10/31/1996CA2214029A1 Single-vial formulations of dna/lipid complexes
10/31/1996CA2203435A1 N-sulfoxy anhydrides, a process for the preparation thereof and its use for the preparation of bioactive substances having ace inhibitory action
10/31/1996CA2192576A1 Remedy for allergic diseases in the region of the nose
10/30/1996EP0739903A1 Carbamoylmethylurea derivative
10/30/1996EP0739902A2 Novel oligoribonucleotide derivatives and application thereof to antiviral agents
10/30/1996EP0739901A2 Novel oligoribonucleotide derivatives and application thereof to antiviral agents
10/30/1996EP0739900A2 Novel oligoribonucleotide derivatives and application thereof to antiviral agents
10/30/1996EP0739899A2 Novel oligoribonucleotide derivatives and application thereof to antiviral agents
10/30/1996EP0739898A2 Phosphonomonoester nucleic acids, methods for their preparation and their use
10/30/1996EP0739892A2 Chromone derivatives
10/30/1996EP0739891A2 Substituted heterocycles
10/30/1996EP0739887A1 Cyclohexane compounds, process for their preparation and pharmaceutical compositions containing them
10/30/1996EP0739886A2 Selective thrombin inhibitors
10/30/1996EP0739881A2 Piperidine derivatives
10/30/1996EP0739634A2 Porphyrin metal complex-albumin inclusion compound and oxygen carrier composition comprising the same
10/30/1996EP0739629A1 Associations comprising (-)hydroxycitrate and having new therapeutical activities
10/30/1996EP0739628A2 A new composition containing selegiline
10/30/1996EP0739627A1 Use of glycyrrhizinic acid and its metabolite (glycyrrhetinic acid) as active ingredient in the manufacture of a medicament for the treatment of malignant diseases (cancer)
10/30/1996EP0739351A1 Monomeric diols and phosphate linked oligomers formed therefrom
10/30/1996EP0739347A1 Hydrazides of phosphorylated carboxylic acids having therapeutic activity
10/30/1996EP0739345A1 Cyclic polyamines
10/30/1996EP0739344A1 Antiparasitic pyrrolobenzoxazine compounds
10/30/1996EP0739343A1 Water soluble onium salt of taxo-diterpenoid
10/30/1996EP0739342A1 Pyridine modulators of acetylcholine receptors
10/30/1996EP0739340A1 Phenyl heterocycles as cox-2 inhibitors
10/30/1996EP0739338A1 Novel serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide
10/30/1996EP0739336A1 Gem-disubstituted azacyclic tachykinin antagonists
10/30/1996EP0739335A1 Pyrrolidine-containing monomers and oligomers
10/30/1996EP0739210A1 Methods and compositions for the treatment of a host with a cellular proliferative disease
10/30/1996EP0739208A1 Flavin derivatives as anti-viral agents
10/30/1996EP0739207A1 Enteral formula with ribo-nucleotides
10/30/1996EP0739206A1 Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof
10/30/1996EP0739205A1 Use of n-alkyl derivatives of 1,5-dideoxy-1,5-imino-d-glucitol for the treatment of hepatitis b virus infections
10/30/1996EP0739203A1 Method for treating diseases mediated by cellular proliferation in response to pdgf, egf, fgf and vegf
10/30/1996EP0739202A1 Use of bis(amidinobenzimidazoles) in the manufacture of medicament for inhibiting retroviral integrase
10/30/1996EP0739201A1 Microgranules of 5-nitro imidazole derivatives
10/30/1996EP0739200A1 Therapeutic substituted guanidines
10/30/1996EP0739199A1 Estradiol penetration intensifier for transdermal administration
10/30/1996EP0695301B1 Indole derivatives as 5-ht1-like agonists for use in migraine
10/30/1996EP0634013B1 System for the detection of nicotine and/or nicotine metabolite
10/30/1996EP0573576B1 Compositions for topical administration of pharmaceutically active agents
10/30/1996EP0571593B1 New non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them
10/30/1996EP0552379B1 Dihydropyridine derivatives, and process for their preparation
10/30/1996EP0538301B1 Hiv-inhibiting benzeneacetamide derivatives
10/30/1996EP0532595B1 The pharmacological use of certain cystine derivatives
10/30/1996CN1134702A Alkoxy alkyl carbamates from imidazo (1.2-a) pyridines
10/30/1996CN1134700A Novel taxoids, their preparation and pharmaceutical compositions containing them
10/30/1996CN1134699A Succinamic acid compound, process for producing the same, and use thereof